Lunai Bioworks Inc.
LNAI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001527728
No open-market purchases or sales by Lunai Bioworks Inc. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $641.0K in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Lunai Bioworks Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 39
- −4 vs. Q3 2022
- Shares held
- 3.63M
- −157.8K (−4.2%) vs. Q3 2022
- Total value
- $3.74M
- −$3.13M (−45.6%) vs. Q3 2022
- New holders
- 3
- 14 more added
- Sold out
- 7
- 13 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LNAI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 16 | $641.0K |
| Q1 2026 | 29 | $403.3K |
| Q4 2025 | 24 | $981.7K |
| Q3 2025 | 20 | $1.38M |
| Q2 2025 | 45 | $4.17M |
| Q1 2025 | 63 | $12.0M |
| Q4 2024 | 58 | $18.5M |
| Q3 2024 | 50 | $7.13M |
| Q2 2024 | 39 | $24.8M |
| Q1 2024 | 41 | $19.2M |
| Q4 2023 | 36 | $8.16M |
| Q3 2023 | 21 | $6.65M |
| Q2 2023 | 32 | $1.13M |
| Q1 2023 | 40 | $3.02M |
| Q4 2022 | 39 | $3.74M |
| Q3 2022 | 43 | $6.87M |
| Q2 2022 | 51 | $7.64M |
| Q1 2022 | 43 | $21.5M |
| Q4 2021 | 44 | $18.0M |
| Q3 2021 | 34 | $10.2M |
| Q2 2021 | 37 | $13.3M |
| Q1 2021 | 41 | $9.60M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Lunai Bioworks Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Credit Suisse AG | 1 | $1 | 0.00% | −226−99.6% | Reduced |
| Citadel Advisors LLC | 1 | $1 | 0.00% | +1 | New |
| FMR LLC | 1,289 | $1.33K | 0.00% | −501−28.0% | Reduced |
| Legal & General Group Plc | 1,653 | $1.70K | 0.00% | 00.0% | Unchanged |
| Ameritas Investment Partners, Inc. | 1,482 | $1.85K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 1,902 | $1.96K | 0.00% | +1,602+534.0% | Added |
| Royal Bank of Canada | 3,296 | $3.00K | 0.00% | +3,054+1,262.0% | Added |
| Amalgamated Bank | 4,279 | $4.00K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 5,307 | $5.47K | 0.00% | +4,469+533.3% | Added |
| BNP Paribas Arbitrage, SA | 5,429 | $5.59K | 0.00% | −3,748−40.8% | Reduced |
| UBS Group AG | 6,106 | $6.29K | 0.00% | +6,106 | New |
| Tower Research Capital LLC (TRC) | 7,680 | $8.00K | 0.00% | +3,196+71.3% | Added |
| California State Teachers Retirement System | 7,889 | $8.13K | 0.00% | +89+1.1% | Added |
| American International Group, Inc. | 9,347 | $9.63K | 0.00% | −35−0.4% | Reduced |
| Alliancebernstein L.P. | 10,400 | $10.7K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 11,186 | $12.0K | 0.00% | +621+5.9% | Added |
| Dimensional Fund Advisors LP | 12,754 | $13.0K | 0.00% | −7,688−37.6% | Reduced |
| AQR Capital Management LLC | 20,800 | $21.4K | 0.00% | −5,005−19.4% | Reduced |
| Belvedere Trading LLC | 23,572 | $24.3K | 0.01% | +23,572 | New |
| Bank of America Corp | 23,654 | $24.4K | 0.00% | −4,013−14.5% | Reduced |
| Blair William & Co | 26,000 | $26.8K | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 29,290 | $30.0K | 0.00% | +151+0.5% | Added |
| New York State Common Retirement Fund | 31,000 | $31.9K | 0.00% | 00.0% | Unchanged |
| Allspring Global Investments Holdings, LLC | 36,268 | $37.4K | 0.00% | −793−2.1% | Reduced |
| Deutsche Bank AG | 46,467 | $47.9K | 0.00% | +133+0.3% | Added |
| Charles Schwab Investment Management Inc | 50,951 | $52.5K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 52,814 | $54.0K | 0.00% | +19,631+59.2% | Added |
| Bank of New York Mellon Corp | 55,005 | $56.7K | 0.00% | 00.0% | Unchanged |
| Cantor Fitzgerald, L. P. | 59,724 | $62.0K | 0.00% | +13,814+30.1% | Added |
| Morgan Stanley | 71,340 | $73.5K | 0.00% | −77,568−52.1% | Reduced |
| Two Sigma Advisers, LP | 78,100 | $80.4K | 0.00% | −33,100−29.8% | Reduced |
| Two Sigma Investments, LP | 89,667 | $92.4K | 0.00% | −50,316−35.9% | Reduced |
| Invesco Ltd. | 101,400 | $104.4K | 0.00% | 00.0% | Unchanged |
| Nuveen Asset Management, LLC | 124,577 | $128.0K | 0.00% | −16,582−11.7% | Reduced |
| Northern Trust Corp | 161,216 | $166.1K | 0.00% | +11,680+7.8% | Added |
| State Street Corp | 305,608 | $314.8K | 0.00% | −10,716−3.4% | Reduced |
| Geode Capital Management, LLC | 318,783 | $328.0K | 0.00% | +1240.0% | Added |
| Vanguard Group Inc | 758,703 | $781.5K | 0.00% | +3,540+0.5% | Added |
| BlackRock Inc. | 1,077,241 | $1.11M | 0.00% | +34,830+3.3% | Added |
| Rafferty Asset Management, LLC | 0 | $0 | 0.00% | −26,273−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −16,892−100.0% | Sold out |
| Gladius Capital Management LP | 0 | $0 | 0.00% | −15,225−100.0% | Sold out |
| ETF Managers Group, LLC | 0 | $0 | 0.00% | −15,625−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| Clear Street Markets LLC | 0 | $0 | 0.00% | −70−100.0% | Sold out |
| Ellis Investment Partners, LLC | 0 | $0 | 0.00% | −50−100.0% | Sold out |